Angelique E. Weel

Zuideinde, OV, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Impact of musculoskeletal joint complaints on quality of life in patients with inflammatory bowel disease: a cross-sectional study.

Impact of musculoskeletal joint complaints on quality of life in patients with inflammatory bowel disease: a cross-sectional study.

Journal: BMJ open

Published: November 14, 2024

Is the QCI framework suited for monitoring outcomes and costs in a teaching hospital using value-based healthcare principles? A retrospective cohort study.

Is the QCI framework suited for monitoring outcomes and costs in a teaching hospital using value-based healthcare principles? A retrospective cohort study.

Journal: BMJ open

Published: May 01, 2024

Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial.

Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial.

Journal: Annals of the rheumatic diseases

Published: April 07, 2020

Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial.

Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial.

Journal: Annals of the rheumatic diseases

Published: April 06, 2020

Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study.

Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study.

Journal: Rheumatology international

Published: April 10, 2018

Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases.

Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseases.

Journal: AIDS (London, England)

Published: November 08, 2017

Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice.

Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice.

Journal: The Journal of rheumatology

Published: July 03, 2017

No clear association between ultrasound remission and health status in rheumatoid arthritis patients in clinical remission.

No clear association between ultrasound remission and health status in rheumatoid arthritis patients in clinical remission.

Journal: Rheumatology (Oxford, England)

Published: March 16, 2016

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial.

Journal: Annals of the rheumatic diseases

Published: May 03, 2014

Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis.

Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis.

Journal: Annals of the rheumatic diseases

Published: December 04, 2013

Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study.

Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study.

Journal: Annals of the rheumatic diseases

Published: November 03, 2012

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial.

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial.

Journal: Annals of the rheumatic diseases

Published: June 09, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026